- Home
- CRMD vs LEU Comparison
CRMD vs LEU Comparison
Compare CRMD & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- LEU
- Stock Information
- Founded
- CRMD 2006
- LEU 1998
- Country
- CRMD United States
- LEU United States
- Employees
- CRMD N/A
- LEU N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- CRMD Health Care
- LEU Industrials
- Exchange
- CRMD Nasdaq
- LEU Nasdaq
- Market Cap
- CRMD 973.3M
- LEU 3.2B
- IPO Year
- CRMD 2010
- LEU 1998
- Fundamental
- Price
- CRMD $11.40
- LEU $176.00
- Analyst Decision
- CRMD Strong Buy
- LEU Buy
- Analyst Count
- CRMD 7
- LEU 9
- Target Price
- CRMD $17.33
- LEU $165.63
- AVG Volume (30 Days)
- CRMD 2.5M
- LEU 1.4M
- Earning Date
- CRMD 08-13-2025
- LEU 08-05-2025
- Dividend Yield
- CRMD N/A
- LEU N/A
- EPS Growth
- CRMD N/A
- LEU 40.85
- EPS
- CRMD 0.28
- LEU 6.39
- Revenue
- CRMD $82,553,827.00
- LEU $471,400,000.00
- Revenue This Year
- CRMD $238.38
- LEU $3.22
- Revenue Next Year
- CRMD $53.52
- LEU $9.91
- P/E Ratio
- CRMD $41.86
- LEU $27.47
- Revenue Growth
- CRMD N/A
- LEU 58.72
- 52 Week Low
- CRMD $3.61
- LEU $33.51
- 52 Week High
- CRMD $17.43
- LEU $211.31
- Technical
- Relative Strength Index (RSI)
- CRMD 39.52
- LEU 60.56
- Support Level
- CRMD $12.14
- LEU $164.91
- Resistance Level
- CRMD $17.43
- LEU $184.43
- Average True Range (ATR)
- CRMD 0.69
- LEU 15.53
- MACD
- CRMD -0.51
- LEU -3.14
- Stochastic Oscillator
- CRMD 4.60
- LEU 38.54
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.